Compare
Compare Drug Products
Pharmacies sometimes switch which manufacturer's version of a drug they stock. Enter both product names or DINs — usually printed right on the label or bottle — to see how they compare.
First product
vsJAKAVI
Second product
OPZELURA
This comparison shows regulatory facts from Health Canada. It does not determine whether these products are interchangeable — ask your pharmacist before switching.
↔ Swipe to see both products
| JAKAVI | OPZELURA | |
|---|---|---|
| Manufacturer | NOVARTIS PHARMACEUTICALS CANADA INC | INCYTE CORPORATION |
| Active ingredient | RUXOLITINIB (RUXOLITINIB PHOSPHATE) | RUXOLITINIB (RUXOLITINIB PHOSPHATE) |
| Strength | 20MG | 1.5% |
| Dosage form | Tablet | Cream |
| Route | Oral | Topical |
| Health Canada status | Marketed | Marketed |
| Shortage status | No current shortage | No current shortage |
| Recall / safety alert | None on file | None on file |
Same active ingredientDifferent strengthDifferent dosage formDifferent route